Additional file 1: of Use of anti-tuberculosis drugs among newly diagnosed pulmonary tuberculosis inpatients in China: a retrospective study

Multilingual abstracts in the six official working languages of the United Nations. (PDF 371 kb

Additional file 1: Table S1. of The effect of NCMS on catastrophic health expenditure and impoverishment from tuberculosis care in China

Main components of OOPa payment for TB care in China, 2012. Table S2. Demographic profile of the study sites in 2012, China. (DOCX 16 kb

Additional file 1: of Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China: study protocol for a cluster randomised controlled trial

Informed consent form and patient information sheet. (DOCX 33 kb

Effect of sensitivity and MDR-TB prevalence on cost of diagnosis using Genechip and conventional DST.

<p>Effect of sensitivity and MDR-TB prevalence on cost of diagnosis using Genechip and conventional DST.</p

Cost of diagnosing a single case of MDR-TB, taking loss into account.

a<p>The cost of DST calculated based on a rate of specimens positive in smear examination and negative in culture of 91.48% and a validity rate of 99%;</p>b<p>The cost of Genechip calculated based on a validity rate of 85%.</p

Average unit cost of conventional DST.

<p>Average unit cost of conventional DST.</p

Effect of the price of Genechip on the cost of diagnosis.

<p>A–D represents the costs of diagnosing a single case of MDR-TB by Genechip with various sensitivities at various prevalence rates when the price of Genechip is adjusted to 50%, 80%, 150%, and 200% of the current price level.</p

Average unit cost of Genechip.

<p>Average unit cost of Genechip.</p

Patient enrollment and testing flow chart.

<p>Patient enrollment and testing flow chart.</p

Performance of the PURE-LAMP test for TB detection in TB suspects based on spot sputum.

<p>Performance of the PURE-LAMP test for TB detection in TB suspects based on spot sputum.</p